A global study reveals a disturbing rise in early-onset gastric cancer, a disease once predominantly affecting older adults ...

Historically, gastric cancer has been a disease primarily affecting the elderly. However, emerging research indicates a dramatic change: younger adults are now increasingly at risk, with cases ...

Telisotuzumab adizutecan is under clinical development by AbbVie and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I drugs for Gastric Cancer have a 74% phase transition ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

Testing showed Roberts had “quite advanced” cancer in the lower part of her stomach - she had no symptoms. “It was a shock ...

Dear Dr. Roach: Is 18 years a record for living without a stomach? A family member had stomach cancer when he was 70 and had ...